EVEREST LIFE SCI
GenericsEVEREST LIFE SCI is a generic drug manufacturer focused on Dermatology.
EVEREST LIFE SCI's Key Drugs
EVEREST LIFE SCI's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
EVEREST LIFE SCI's Recent FDA Approvals
New NDA/BLA approvals for EVEREST LIFE SCI over the last two years — novel drugs only, excluding generics and label supplements.
EVEREST LIFE SCI's Therapeutic Areas
EVEREST LIFE SCI's approved drugs and pipeline span 1 therapeutic area, led by Dermatology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
EVEREST LIFE SCI's Top Competitors
EVEREST LIFE SCI's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Baxter, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
EVEREST LIFE SCI Pipeline Snapshot
Active clinical trials for EVEREST LIFE SCI across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Dermatology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1979-07-03
- Latest
- 2025-04-23
- Applications
- 2